REFERENCES
- Pagano L, Valentini CG, Posteraro B et al. Federazione Italiana di Micopatologia Umana ed Animale and European Con-federation of Medical Mycology (FIMUA-ECMM) survey of Zy-gomycosis in Italy. J Chemother 2009; 21 (3): 322–329.
- White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylo-genetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR protocols: a guide to methods and applications. Academic Press Inc, 1990, pp 315–322
- National Committee for Clinical Laboratory Stan-dards. 2002. Reference method for broth dilution antifungal sus-ceptibility testing of filamentous fungi. Approved standard. NCCLS document M38-A. National Committee for Clinical Lab-oratory Standards, Wayne, Pa.
- Dannaoui E, Meletiadis J, Mouton JW, Meis JFGM, Ver-weij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45–52.
- Gil-Lamaignere C, Hess R, Salvenmoser S, Heyn K, Kappe R, Muller FM. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zy-gomycetes. J Antimicrob Chemother 2005; 55: 1016–1019.
- Dannaoui E, Mouton JW, Meis JF, Verweij PE. Efficacy of antifungal therapy in a nonneutropenic murine model of zy-gomycosis. Antimicrob Agents Chemother 2002; 46: 1953–1959.
- Sun QN, Najvar LK, Bocanegra R et al. In vivo activity of posaconazole against Mucor spp in a immunosuppressed mouse model. Antimicrob Agents Chemother 2002; 46: 2310–2312.